scholarly journals Spontaneous Tumor Lysis Syndrome due to Uterine Leiomyosarcoma with Lung Metastases

2017 ◽  
Vol 2017 ◽  
pp. 1-4 ◽  
Author(s):  
Vivek Alaigh ◽  
Debapriya Datta

Tumor lysis syndrome (TLS) is an oncologic emergency characterized by a combination of metabolic derangements (hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia) caused by rapid turnover from cell destruction in certain cancers. These metabolic derangements can lead to seizures, cardiac arrhythmias, renal failure, and death. TLS is usually seen after the initiation of chemotherapy for hematologic malignancies. TLS occurring spontaneously, without initiation of chemotherapy, is rare and its occurrence in solid tumors is rarer still. We report a case of spontaneous TLS in a patient with leiomyosarcoma of the uterus, with metastasis to lung. Such a case has never been reported before.

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Neeraj Saini ◽  
Kyeong Pyo Lee ◽  
Smita Jha ◽  
Sanket Patel ◽  
Neelima Bonthu ◽  
...  

Tumor lysis syndrome (TLS) is an oncologic emergency that is caused by massive tumor cell lysis. It is commonly associated with hematological cancers like leukemia and lymphoma and uncommonly with solid nonhematologic tumors as well. However, spontaneous tumor lysis syndrome (STLS) without any cytotoxic chemotherapy rarely occurs in solid tumors. We describe a case of STLS in a metastatic adenocarcinoma of unknown primary and review the literature of STLS in solid non-hematologic tumors to identify various risk factors for pathogenesis of this entity.


CJEM ◽  
2017 ◽  
Vol 20 (S2) ◽  
pp. S41-S43 ◽  
Author(s):  
Ross Berringer

AbstractAcute tumor lysis syndrome in the absence of cytotoxic therapy is an uncommon event but has been reported with hematologic malignancies. The case described below illustrates spontaneous tumor lysis syndrome in the context of a rapidly proliferating metastatic colonic adenocarcinoma. Clinicians should consider ordering phosphate, uric acid, and calcium when assessing patients with recently diagnosed or suspected malignancy.


2017 ◽  
Vol 10 (1) ◽  
pp. 392-395 ◽  
Author(s):  
Boonphiphop Boonpheng ◽  
Ghulam Murtaza ◽  
David Ginn

Tumor lysis syndrome is an oncologic emergency that usually occurs after chemotherapy in patients with hematologic malignancies. Tumor lysis syndrome is rare in cases of solid tumors, especially when it occurs spontaneously. Herein, we present a case of spontaneous tumor lysis syndrome in a 55-year-old woman who presented with dyspnea and was found to have extensive metastatic small cell lung cancer. She developed acute oliguric renal failure and multiple electrolyte abnormalities requiring hemodialysis. The findings of this case suggest that clinicians should maintain a high index of suspicion for patients with malignancies who demonstrate the classic symptom of laboratory abnormalities even in the absence of chemotherapy.


2003 ◽  
Vol 325 (1) ◽  
pp. 38-40 ◽  
Author(s):  
Eleonora Vaisban ◽  
Ofri Mosenzon ◽  
Maya Kolin ◽  
Yvona Horn ◽  
Andrei Braester

2005 ◽  
Vol 53 (1) ◽  
pp. S296.6-S297
Author(s):  
S. Agnani ◽  
R. Gupta ◽  
N. K. Atray ◽  
T. J. Vachharajani

2011 ◽  
Vol 29 (17) ◽  
pp. e494-e496 ◽  
Author(s):  
Konstantin Schlick ◽  
Gernot Schilcher ◽  
Peter Krisper ◽  
Peter Neumeister ◽  
Werner Linkesch ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-12 ◽  
Author(s):  
Danica Maria Vodopivec ◽  
Jose Enrique Rubio ◽  
Alessia Fornoni ◽  
Oliver Lenz

Tumor lysis syndrome (TLS) is characterized by hyperuricemia, hyperkalemia, hyperphosphatemia, and secondary hypocalcemia in patients with a malignancy. When these laboratory abnormalities develop rapidly, clinical complications such as cardiac arrhythmias, acute renal failure, seizures, or death may occur. TLS is caused by rapid release of intracellular contents by dying tumor cells, a condition that is expected to be common in hematologic malignancies. However, TLS rarely occurs with solid tumors, and here we present the second chemotherapy-induced TLS in a patient with advanced gastric adenocarcinoma to be reported in the literature. We also provide information regarding the total cases of TLS in solid tumors reported from 1977 to present day. Our methodology involved identifying key articles from existing reviews of the literature and then using search terms from these citations in MEDLINE to find additional publications. We relied on a literature review published in 2003 by Baeksgaard et al., where they gathered all total 45 cases reported from 1977 to 2003. Then, we looked for new reported cases from 2004 to present day. All reports (case reports, brief reports, letters to editor, correspondence, reviews, journals, and short communications) identified through these searches were reviewed and included.


2016 ◽  
Vol 64 (1) ◽  
pp. 235-237 ◽  
Author(s):  
Xavier Gbaguidi ◽  
Laura Goodrich ◽  
Frédéric Roca ◽  
Philippe Suel ◽  
Philippe Chassagne

Sign in / Sign up

Export Citation Format

Share Document